On January 27th, we were honored to host the General Director and the European Project Design Services team from Rome Technopole, the regional innovation ecosystem, at our headquarters.
As co-leaders of Flagship Project 7, Takis plays a pivotal role in driving the development of advanced laboratories for diagnostic and therapeutic biopharmaceutical solutions.
This project is a key initiative to foster cutting-edge research and innovation in biotechnology, strengthening Rome’s position as a hub for scientific and healthcare advancements.
During the visit, we showcased our expertise in innovative delivery platforms, regulating gene activity, and enhancing immune responses, highlighting how our technologies are advancing the fields of vaccines, monoclonal antibodies, and therapies targeting tumor antigens involved in cancer progression as well as infectious diseases.
At Takis, our mission is to develop therapeutic vaccines and monoclonal antibodies to combat both cancer and infectious diseases, while fostering strong partnerships with academia, industry, and public institutions.
Through our leadership in Flagship Project 7, we aim to shape the future of healthcare innovation not only regionally but across Europe.
